KBI
trans-4-({9-[(3S)-tetrahydrofuran-3-yl]-8-[(2,4,6-trifluorophenyl)amino]-9H-purin-2-yl}amino)cyclohexanol
Find entries where: KBI
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | trans-4-({9-[(3S)-tetrahydrofuran-3-yl]-8-[(2,4,6-trifluorophenyl)amino]-9H-purin-2-yl}amino)cyclohexanol |
Identifiers | 4-[[9-[(3S)-oxolan-3-yl]-8-[[2,4,6-tris(fluoranyl)phenyl]amino]purin-2-yl]amino]cyclohexan-1-ol |
Formula | C21 H23 F3 N6 O2 |
Molecular Weight | 448.442 |
Type | NON-POLYMER |
Isomeric SMILES | c1c(cc(c(c1F)Nc2nc3cnc(nc3n2[C@H]4CCOC4)NC5CCC(CC5)O)F)F |
InChI | InChI=1S/C21H23F3N6O2/c22-11-7-15(23)18(16(24)8-11)28-21-27-17-9-25-20(26-12-1-3-14(31)4-2-12)29-19(17)30(21)13-5-6-32-10-13/h7-9,12-14,31H,1-6,10H2,(H,27,28)(H,25,26,29)/t12-,13-,14-/m0/s1 |
InChIKey | IBGLGMOPHJQDJB-IHRRRGAJSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 55 |
Chiral Atom Count | 1 |
Bond Count | 59 |
Aromatic Bond Count | 16 |
Drug Info: DrugBank
DrugBank ID | DB11798 |
---|---|
Name | Tanzisertib |
Groups | investigational |
Description | Tanzisertib has been used in trials studying the treatment of Fibrosis, Discoid Lupus, Pulmonary Fibrosis, Interstitial Lung Disease, and Lung Diseases, Interstitial, among others. |
Synonyms |
|
Categories |
|
CAS number | 899805-25-5 |